Mapping inequalities in health service coverage in Africa: a scoping review.

Publication date: Nov 24, 2024

In this scoping review, we aim to consolidate the evidence on inequalities in service coverage in Africa using a comprehensive set of stratifiers. These stratifiers include place of residence, race/ethnicity/culture/language, occupation, gender/sex, religion, education, socioeconomic status and social capital. Our approach provides a more holistic understanding of the different dimensions of inequality in the context of universal health coverage (UHC). We conducted a scoping review following the Joanna Briggs Institute Manual for Evidence Synthesis. We searched MEDLINE, Embase, Web of Science, CINAHL, PyscINFO, Cochrane Library, Google Scholar and Global Index Medicus for articles published between 1 January 2005 and 29 August 2022 examining inequalities in utilisation of health services for reproductive, maternal, newborn and child health (RMNCH), infectious or non-communicable diseases in Africa. We included any empirical research that assessed inequalities in relation to services for RMNCH (eg, family planning), infectious diseases (eg, tuberculosis treatment) and non-communicable diseases (eg, cervical cancer screening) in Africa. The data abstraction process followed a stepwise approach. A pilot-tested form capturing study setting, inequality assessment and service coverage indicators was developed and finalised. Data were extracted by one reviewer and cross-checked by another, with discrepancies resolved through consensus meetings. If a consensus was not reached, senior reviewers made the final decision. We used a narrative approach to describe the study characteristics and mapped findings against PROGRESS-Plus stratifiers and health service indicators. Quantitative findings were categorised as ‘proequity’, ‘antiequity’ or ‘equal’ based on service utilisation across social groups. We included 178 studies in our review, most studies published within the last 5 years (61. 1%). Most studies assessed inequality using socioeconomic status (70. 6%), followed by age (62. 4%), education (60. 7%) and place of residence (59. 0%). Few studies focused on disability, social capital and ethnicity/race and intersectionality of stratifiers. Most studies were on RMNCH services (53. 4%) and infectious disease services (43. 3%). Few studies were qualitative or behavioural analyses. Results highlight significant inequalities across different equity stratifiers and services with inconsistent trends of inequalities over time after the implementation of strategies to increase demand of services and strengthen health systems. There is a need to examine equity in service coverage for a variety of health conditions among various populations beyond the traditional classification of social groups. This also requires using diverse research methods identifying disparities in service use and various barriers to care. By addressing these knowledge gaps, future research and health system reforms can support countries in moving closer to achievement of UHC targets.

Open Access PDF

Concepts Keywords
August Africa
Google Health Equity
Pilot Health Services
Socioeconomic Health Services Accessibility
Tuberculosis Healthcare Disparities
Humans
PUBLIC HEALTH
Socioeconomic Factors
Universal Health Insurance

Semantics

Type Source Name
disease MESH non-communicable diseases
disease MESH infectious diseases
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH cervical cancer
disease IDO process
drug DRUGBANK Aspartame
pathway REACTOME Infectious disease
disease IDO infectious disease
drug DRUGBANK Trestolone
drug DRUGBANK Serine
drug DRUGBANK Coenzyme M
drug DRUGBANK Abacavir
drug DRUGBANK Methionine
drug DRUGBANK Tropicamide
disease MESH neglected tropical diseases
drug DRUGBANK Water
disease MESH marital status
disease IDO facility
disease IDO country
disease MESH emergency
pathway REACTOME Translation
drug DRUGBANK Methacholine
disease MESH AIDS
drug DRUGBANK Ethionamide
disease IDO history
disease MESH pregnancy outcome
disease MESH Malaria
pathway KEGG Malaria
drug DRUGBANK Acridine Carboxamide
disease MESH HIV infection
pathway REACTOME HIV Infection
disease IDO intervention
disease MESH uncertainty
disease MESH Hypertension
disease MESH parasitemia
drug DRUGBANK Dimethyl sulfone
disease MESH treatment delays
drug DRUGBANK Spinosad
disease MESH lymphatic filariasis
disease MESH Health Services Accessibility

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *